Workflow
碧迪发布致客户的公开信——关于美国高维流式禁令的应对方案

Core Viewpoint - The article discusses the recent developments regarding the temporary final rule (IFR) issued by the U.S. government on January 16, 2025, which restricts the export of certain flow cytometers to China. The company, BD, is actively communicating with the U.S. government to seek revisions to this rule and has successfully obtained export licenses to continue serving its customers in China [1][3][5]. Summary by Sections - The U.S. government has approved BD's export license application, allowing the company to continue providing flow cytometers to its customers in China. This approval is seen as a positive step towards compliance with U.S. regulations [3][4][5]. - BD has received its first export license on April 18, 2025, which permits the sale, delivery, installation, and servicing of BD's spectral and 26+ channel flow cytometers in China. This license provides a clear path for BD to operate within the regulatory framework [1][3][4]. - The company is now officially restarting marketing efforts for several instruments in China, including the BD FACSDiscover™ S8 cell sorter and various models of the BD FACSymphony™ series, aiming to establish new collaborations [4][5].